Table 4.
Variable | Number ofstudies | OR | 95% CI | Severe | Non-severe | χ 2‡ | I 2§ | Z † | p |
---|---|---|---|---|---|---|---|---|---|
Male | 40 | 1.46 | 1.34–1.60 | 1859 | 5120 | 43.78 | 11 | 8.29 | <0.00001 |
Female | 40 | 0.68 | 0.62–0.74 | 1159 | 4087 | 45.84 | 15 | 8.49 | <0.00001 |
Clinical features | |||||||||
Fever | 34 | 1.24 | 0.96–1.60 | 1964 | 5955 | 102.36 | 68 | 1.67 | 0.09 |
Cough | 34 | 1.45 | 1.18–1.78 | 1660 | 4798 | 88.16 | 63 | 3.55 | 0.0004 |
Fatigue | 34 | 1.40 | 1.14–1.72 | 911 | 2287 | 91.54 | 64 | 3.21 | 0.001 |
Sore throat | 24 | 1.16 | 0.81–1.67 | 200 | 972 | 73.68 | 69 | 0.81 | 0.42 |
Dyspnea | 34 | 4.20 | 3.09–5.72 | 1534 | 8387 | 226.03 | 85 | 9.13 | <0.00001 |
Headache | 28 | 0.95 | 0.69–1.31 | 232 | 736 | 66.56 | 59 | 0.31 | 0.76 |
Diarrhea | 33 | 1.25 | 0.98–1.61 | 434 | 979 | 69.95 | 54 | 1.80 | 0.07 |
Nausea or vomiting | 22 | 1.28 | 0.85–1.92 | 169 | 516 | 67.31 | 69 | 1.19 | 0.23 |
Co-morbidities | |||||||||
Hypertension | 35 | 1.98 | 1.62–2.42 | 1315 | 2333 | 107.88 | 68 | 6.62 | <0.00001 |
Diabetes | 37 | 2.04 | 1.67–2.50 | 741 | 1316 | 80.57 | 55 | 6.97 | <0.00001 |
Cancer | 28 | 1.75 | 1.40–2.18 | 142 | 221 | 36.70 | 26 | 4.92 | <0.00001 |
COPD | 28 | 1.90 | 1.49–2.41 | 131 | 178 | 46.70 | 42 | 5.26 | <0.00001 |
Cardiovascular disease | 31 | 2.78 | 2.00–3.86 | 452 | 694 | 120.06 | 75 | 6.10 | <0.00001 |
Chronic kidney disease | 20 | 2.74 | 1.68–4.48 | 260 | 289 | 72.08 | 74 | 4.03 | <0.00001 |
Complications | |||||||||
ARDS | 19 | 42.69 | 21.62–84.31 | 994 | 258 | 158.58 | 89 | 10.81 | <0.00001 |
Shock | 11 | 23.95 | 9.50–60.35 | 180 | 21 | 23.84 | 58 | 6.74 | <0.00001 |
Acute kidney injury | 17 | 11.12 | 6.07–20.38 | 560 | 263 | 102.42 | 84 | 7.80 | <0.00001 |
Arrhythmia | 8 | 21.23 | 10.40–43.30 | 263 | 42 | 19.27 | 64 | 8.40 | <0.00001 |
Treatments | |||||||||
Antiviral | 25 | 2.18 | 1.43–3.34 | 992 | 3345 | 86.40 | 76 | 3.60 | 0.0003 |
Antibiotics | 22 | 5.96 | 3.32–10.69 | 1296 | 3398 | 97.07 | 82 | 5.98 | <0.00001 |
Glucocorticoids | 28 | 6.12 | 4.01–9.34 | 1347 | 1420 | 258.31 | 90 | 8.40 | <0.00001 |
Oxygen support | 19 | 1.22 | 0.43–3.44 | 1104 | 2756 | 534.83 | 97 | 0.37 | 0.71 |
CRRT | 16 | 18.92 | 8.20–43.66 | 183 | 32 | 34.53 | 57 | 6.89 | <0.00001 |
NIV | 15 | 41.27 | 15.24–111.77 | 599 | 87 | 119.85 | 88 | 7.32 | <0.00001 |
OR: odds ratio; 95% CI: 95% confidence interval; ARDS: acute respiratory distress syndrome; COPD: chronic obstructive pulmonary disease; CRRT: continuous renal replacement therapy; NIV: noninvasive ventilation.
Chi-squared test for heterogeneity.
I2 index to quantify the degree of heterogeneity.
Z-statistics.